<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04109950</url>
  </required_header>
  <id_info>
    <org_study_id>361-303</org_study_id>
    <secondary_id>2019-000696-16</secondary_id>
    <nct_id>NCT04109950</nct_id>
  </id_info>
  <brief_title>A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia</brief_title>
  <official_title>An Open-label Extension Study to Assess the Safety and Tolerability of SEP-363856 in Subjects With Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunovion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunovion</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical trial to determine the long-term safety and tolerability of an&#xD;
      investigational drug in people with schizophrenia. Participants in the study will receive the&#xD;
      drug being studied. This study is accepting male and female participants between 13 and 65&#xD;
      years old who have been diagnosed with schizophrenia and have completed Study SEP361-301 or&#xD;
      SEP361-302. This study will be conducted in approximately 80 study centers worldwide. The&#xD;
      treatment duration for this study is one (1) year.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An open-label extension study to assess the safety and tolerability of SEP-363856 in subjects&#xD;
      with schizophrenia This is an open-label extension study to evaluate long-term safety and&#xD;
      tolerability of SEP-363856. This is a 52-week, outpatient, multicenter, flexible-dose,&#xD;
      open-label extension study designed to evaluate the long-term safety and tolerability of&#xD;
      SEP-363856 (25 to 100 mg/day) for the treatment of subjects with schizophrenia who have&#xD;
      completed the Treatment Period of one of the two following double-blind studies: Study&#xD;
      SEP361-301 or Study SEP361-302.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 4, 2019</start_date>
  <completion_date type="Anticipated">November 17, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 17, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is a 52-week, outpatient, multicenter, flexible-dose, open-label extension study designed to evaluate the long-term safety and tolerability of SEP-363856 (25 to 100 mg/day) for the treatment of subjects with schizophrenia who have completed the Treatment Period of one of the two following double-blind studies: Study SEP361-301 or Study SEP361-302.&#xD;
The study will consist of two periods: An Open-Label Extension (OLE) Treatment Period (up to 52 weeks); and a Follow-up visit at 7 ±2 days after last study drug dose for subjects who complete the Treatment Period and those who prematurely discontinue from the study.&#xD;
The adolescent cohort includes subjects who were 13 to 17 years of age, at the time of consent in the SEP361-301 study. For adolescent subjects, a reliable informant (e.g., parent, legal guardian, or caregiver) of the subject should accompany the subject at each visit and support and monitor the subject's compliance with taking study medication.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>open - label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of overall Adverse Events (AEs), Serious Adverse Events (AEs), and Adverse Events (AEs) leading to discontinuation</measure>
    <time_frame>53 Weeks</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">555</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>SEP-363856</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SEP-363856 25mg, 50mg, 75mg, 100mg flexibly dosed once daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SEP-363856</intervention_name>
    <description>SEP-363856 25mg, 50mg, 75mg, 100mg tablet flexibly dosed once daily</description>
    <arm_group_label>SEP-363856</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject (or subject's parent/legal guardian for adolescents) must give written&#xD;
             informed consent and privacy authorization prior to participation in the study;&#xD;
             adolescents must also provide informed assent.&#xD;
&#xD;
          2. Subject has completed the Treatment Period of Study SEP361-301 or Study SEP361-302.&#xD;
&#xD;
          3. Subject has not taken any medication other than the study drug and protocol-allowed&#xD;
             medications for the purpose of controlling schizophrenia symptoms during Study&#xD;
             SEP361-301 or SEP361-302.&#xD;
&#xD;
          4. Female subject must have a negative urine pregnancy test at the End of Treatment (EOT)&#xD;
             Visit of Study SEP361-301 or Study SEP361-302.&#xD;
&#xD;
          5. Female subjects of childbearing potential must agree to use highly effective and&#xD;
             reliable contraception throughout the study and for at least 30 days after the last&#xD;
             dose of study drug has been taken.&#xD;
&#xD;
          6. Male subjects must agree to avoid fathering a child and use highly effective methods&#xD;
             of birth control from screening in Study SEP361-301 or Study SEP361-302, until at&#xD;
             least 30 days after the last study drug administration in the present study&#xD;
             (SEP361-303).&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. . Subject answered &quot;yes&quot; to &quot;suicidal ideation&quot; Item 4 (active suicidal ideation with&#xD;
             some intent to act, without specific plan) or Item 5 (active suicidal ideation with&#xD;
             specific plan and intent) on the Columbia Suicide Severity Rating Scale (C-SSRS)&#xD;
             assessment at the End of treatment (EO) Visit of Study SEP361-301 or SEP361-302.&#xD;
&#xD;
          2. Subject has a clinically significant abnormality including physical examination, vital&#xD;
             signs, ECG, or laboratory test at the EOT Visit of Study SEP361-301 or SEP361-302 that&#xD;
             the investigator in consultation with the medical monitor considers to be&#xD;
             inappropriate to allow participation in the study.&#xD;
&#xD;
          3. Subject has a positive urine drug screen (UDS) at the EOT Visit of Study SEP361-301 or&#xD;
             SEP361-302. However, a positive UDS test may not result in exclusion of subjects if&#xD;
             the Investigator determines that the positive test is as a result of prescription&#xD;
             medicine(s). Subjects may enter this study before the urine drug screen results are&#xD;
             received from the central laboratory. However, after receipt and review of the results&#xD;
             any subject meeting this exclusion criterion must be discontinued from the study.&#xD;
             Retesting of the UDS is allowed once with prior approval from the Medical Monitor with&#xD;
             the retest used to determine eligibility&#xD;
&#xD;
          4. Female subject is pregnant or lactating.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>CNS Medical Director</last_name>
    <role>Study Chair</role>
    <affiliation>Sunovion</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>CNS Medical Director</last_name>
    <phone>1-866-503-6351</phone>
    <email>ClinicalTrialDisclosure@sunovion.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Woodland International Research Group, LLC</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Woodland Research Northwest</name>
      <address>
        <city>Rogers</city>
        <state>Arkansas</state>
        <zip>72758</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Synergy San Diego</name>
      <address>
        <city>Lemon Grove</city>
        <state>California</state>
        <zip>91945</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Bari, MD</last_name>
      <phone>619-303-6130</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Collaborative Neuroscience Network</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Walling, MD</last_name>
      <phone>714-799-7799</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alliance for Research</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90807</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Zarate-Rowell, MD</last_name>
      <phone>562-548-8500</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Catalina Research Institute</name>
      <address>
        <city>Montclair</city>
        <state>California</state>
        <zip>91763</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Volk, MD</last_name>
      <phone>909-590-8409</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>California Neuropsychopharmacology Clinical research Institute (CNRI-LA, LLC)</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raymond Manning, MD</last_name>
      <phone>562-928-8601</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>California Neuropsychopharmacology clinical Research Institute</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Benbow, MD</last_name>
      <phone>619-481-5252</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schuster Medical Research Institute</name>
      <address>
        <city>Sherman Oaks</city>
        <state>California</state>
        <zip>91403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Itzchovich-Schuster, MD</last_name>
      <phone>818-788-0746</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fort Lauderdale Behavioral Health Center</name>
      <address>
        <city>Oakland Park</city>
        <state>Florida</state>
        <zip>33334</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>iResearch Atlanta, LLC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saundra Maass-Robinson, MD</last_name>
      <phone>404-537-1281</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Atlanta Center for Medical Research</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30331</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lake Charles Clinical Trials</name>
      <address>
        <city>Lake Charles</city>
        <state>Louisiana</state>
        <zip>70629</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kashinath Yadalam, MD</last_name>
      <phone>337-564-6405</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CBH Health, LLC</name>
      <address>
        <city>Gaithersburg</city>
        <state>Maryland</state>
        <zip>20877</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Litman, MD</last_name>
      <phone>301-251-4702</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hassman Research Institute</name>
      <address>
        <city>Marlton</city>
        <state>New Jersey</state>
        <zip>08053</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard Hassman, MD</last_name>
      <phone>856-452-9901</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>New York State Psychiatric Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Midwest Clinical research Center</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45417</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Otto Dueno, MD</last_name>
      <phone>937-281-0151</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. David Brown, Community Clinical Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78754</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Brown, MD</last_name>
      <phone>512-323-2622</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pillar Clinical Research</name>
      <address>
        <city>Richardson</city>
        <state>Texas</state>
        <zip>75080</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mental Health Centre Prof. Dr. Ivan Temkov - Burgas EOOD, Department for Treatment of Emergency Psychiatric Conditions</name>
      <address>
        <city>Burgas</city>
        <zip>8000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veselin Palazov, MD</last_name>
      <phone>+359888451225</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>State Psychiatric Hospital - Kardzhali, First Women Department, Third Men Department</name>
      <address>
        <city>Kardzhali</city>
        <zip>6600</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rozaliya Rangelova, MD</last_name>
      <phone>+35989903682</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>State Psychiatric Hospital Sv. Ivan Rilski, Department general Psychiatry for Adults, &quot;Closed&quot; type - Men, Department General Psychiatry for Adults, &quot;Closed&quot; Type Women</name>
      <address>
        <city>Novi Iskar</city>
        <zip>1282</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tsveteslava Galabova, MD</last_name>
      <phone>+359888589162</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>State Psychiatric Hospital-Pazardzhik AD, Department for Active Treatment of Men Department for Active Treatment of Women , Department of Active Treatment of Men and Women</name>
      <address>
        <city>Pazardzhik</city>
        <zip>4400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dora Atanasova, MD</last_name>
      <phone>+35934448812</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMHAT-Dr. Georgi Stranski EAD, First Psychiatric Clinic</name>
      <address>
        <city>Pleven</city>
        <zip>5800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maya Stoimenova-Popova, MD</last_name>
      <phone>+359888227165</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMHAT Alexandrovska EAD First Department of Psychiatry at Clinic of Psychiatry</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgi Onchev, MD</last_name>
      <phone>+359898474519</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMHAT Alexandrovska EAD Second Department of Pshychiatry at Clinic of Psychiatry</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vihra Milanova, MD</last_name>
      <phone>+359888941451</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mental Health Center - Veliko Tarnovo EOOD-Department of psychiatry for active treatment of persons with acute psychiotic disorders</name>
      <address>
        <city>Veliko Tarnovo</city>
        <zip>5000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ognyan Nikitov, MD</last_name>
      <phone>+35962622625</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mental Health Center-Vratsa EOOD, Department of General Psychiatry</name>
      <address>
        <city>Vratsa</city>
        <zip>3000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadya Ivanova, MD</last_name>
      <phone>+359887422440</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>LTD Psychoneurological Hospital of Daugavpils</name>
      <address>
        <city>Daugavpils</city>
        <zip>LV-5417</zip>
        <country>Latvia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>SLLC Riga Centre of Psychiatry and Narcology</name>
      <address>
        <city>Riga</city>
        <zip>LV-1005</zip>
        <country>Latvia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>SLLC Psychoneurological Hospital of Strenci</name>
      <address>
        <city>Strenci</city>
        <zip>LV-4730</zip>
        <country>Latvia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inga Bauska, MD</last_name>
      <phone>+37129521701</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>State Budgetary Institution of Healthcare &quot;Regional Clinical Specialized Psychiatric Hospital #1&quot;</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454087</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>State PUblic Institution of Healthcare Leningrad Regional Psychoneurological Dispensary</name>
      <address>
        <city>Leningrad</city>
        <zip>188820</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia Penchul, MD</last_name>
      <phone>+78137864178</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>SBIH of Moscow &quot;Psychiatric Clinical Hospital #4 n.a. P.B. Gannushkin&quot;</name>
      <address>
        <city>Moscow</city>
        <zip>107076</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institution of Healthcare Moscow &quot;Psychiatric Clinical Hospital #1 Named after N.A. Alekseev of Department of Health Moscow&quot;</name>
      <address>
        <city>Moscow</city>
        <zip>117152</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Budgetary institution of Healthcare of Moscow &quot;Psychiatric Hospital №5</name>
      <address>
        <city>Moscow</city>
        <zip>141371</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Budgetary Institution of Healthcare of Nizhniy Novgorod region &quot; Clinical Psychiatric Hospital # 1 of Nizhniy Novgorod</name>
      <address>
        <city>Nizhniy Novgorod</city>
        <zip>603155</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Budgetary Institution of Healthcare of Karelia Republic &quot;Republican Psychiatric Hospital&quot; Mastrosy</name>
      <address>
        <city>Republic Karelia</city>
        <zip>186131</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saint Petersburg State Budgetary Institution of Healthcare &quot;Psychiatric Hospital n.a P.P. Kashchenko:</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>188357</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saint Petersburg State Budgetary Institution of Healthcare &quot;Psychiatric Hosptial named after P.P. Kashchenko, inpatient no 2 legg add: 10</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>190005</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>FSBI &quot;NMRC of Psychiatry and Neurology n.a. V.M. Bekhterev&quot; MoH RF 3, Bekhtereva str, Saint Petersbur, 192019, Russia based on SPb SI of Healthcare &quot;City Psychiatric Hospital #6&quot;</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>191167</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Institution &quot;National Medical Research Center o Psychiatry and Neurology named after V.M. Bekhterev&quot; of the Ministry of Healthcare of the Russian Fereration</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>192019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Institution &quot;National Medical Research Center of Psychiatry and Neurology n. a. V. M. Bekhterev&quot; of the Ministry of Healthcare of the Russian Federation</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>192019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mikhail Ivanov, MD</last_name>
      <phone>+7 921 930 61 67</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Petersburg State Public Institution of Healthcare &quot;City Psychiatric Hospital #3 named after I.I. Skvortson&quot;</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Sofronov, MD</last_name>
      <phone>+78123018654</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>State Budgetary Institution of Healthcrae &quot;Samara Regional Clinical Psychiatric Hospital&quot;</name>
      <address>
        <city>Samara</city>
        <zip>443016</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Institution of Healthcare &quot;Saratov City Clinical Hospital # 2 named after V.I. Razumovskiy&quot; 20 and 21 department</name>
      <address>
        <city>Saratov</city>
        <zip>410028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Barylnik, MD</last_name>
      <phone>+7 927 226 68 50</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>State Institution of Healthcare &quot;Saratov City Clinical Hospital #2 named after V.I. Razumovskiy&quot;, psychiatric departments</name>
      <address>
        <city>Saratov</city>
        <zip>410028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Institution of Healthcare &quot;Regional Clinical Psychiatric Hospital of Saint Sofia&quot;</name>
      <address>
        <city>Saratov</city>
        <zip>410060</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Institution of Healthcare &quot;Engels Psychiatric Hospital&quot; Ministry of Healthcare of Saratov region</name>
      <address>
        <city>Saratov</city>
        <zip>413124</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Institution &quot;National Medical Research Center of Psychiatry and Neurology named after V. M. Bekhterev&quot; of the Ministry of the Healthcare of Russian federation</name>
      <address>
        <city>St. Petersburg</city>
        <zip>192019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinic of Psychiatry, Clinical Center of Serbia</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maja Ivkovic, PhD</last_name>
      <phone>+38163252201</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic of Psychiatry, Clinical Center of Serbia</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milan Latas, Prof.</last_name>
      <phone>+381641303993</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Center &quot;Dr. Dragisa Misovic-Dedinje&quot; Clinic of Psychiatry</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Diligenski, Professor</last_name>
      <phone>+381113679200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute of Mental Health</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cedo Miljevic, MD</last_name>
      <phone>+381628759575</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute of Mental Health</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milica Pejovic Milovancevic, Prof.</last_name>
      <phone>+38163343969</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Special Hospital for Psychiatric Diseases Gornja Toponica</name>
      <address>
        <city>Gornja Toponica</city>
        <zip>18202</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milan Stanojkovic, MD</last_name>
      <phone>+381648596221</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Special Neuropsychiatric Hospital Kovin</name>
      <address>
        <city>Kovin</city>
        <zip>26220</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Special Neuropsychiatric Hospital Kovin</name>
      <address>
        <city>Kovin</city>
        <zip>26220</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jovanka Petrovic, MD</last_name>
      <phone>+3816553529054</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic of Psychiatry, Clinical Center Kragujevac</name>
      <address>
        <city>Kragujevac</city>
        <zip>34000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Goran Mihajlovic, PhD</last_name>
      <phone_ext>+38134300320</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic of Psychiatry, Clinical Center Kragujevac</name>
      <address>
        <city>Kragujevac</city>
        <zip>34000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mirjana Jovanovic, Professor</last_name>
      <phone>+38134370151</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Center Kragujevac, Clinic of Psychiatry</name>
      <address>
        <city>Kragujevac</city>
        <zip>34000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Special Hospital for Psychiatric Diseases Sveti Vracevi, Kralja Petra I</name>
      <address>
        <city>Novi Knezevac</city>
        <zip>23330</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jovan Milovanovic, MD</last_name>
      <phone>+38163239962</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Center of Vojvodina, Clinic of Psychiatry</name>
      <address>
        <city>Novi Sad</city>
        <zip>21000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Regional Psychoneurological Hospital#3, Department of Critical Conditions and Primary Psychotic Episode for Adult Population #1, Ivano-Frankivsk National Medical University, Chair of Psychiatry, Narcology and Medical Pschology</name>
      <address>
        <city>Ivano-Frankivsk</city>
        <zip>76011</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mykhailo Vynnyk, MD</last_name>
      <phone>+380976287390</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Commercial Non-Commercial Enterprise of Kharkiv Regional Council Psychiatric Department of Primary Psychotic Episode</name>
      <address>
        <city>Kharkiv</city>
        <zip>61068</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>State Institution Institute of Neurology, Psychiatry and Narcology of the National Academy of Medical Sciences of Ukraine, Department of Boundary Psychiatry</name>
      <address>
        <city>Kharkiv</city>
        <zip>61068</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nataliya Maruta</last_name>
      <phone>+380677577772</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Noncommercial Enterprise Kherson Regional Institution of Psychiatric Care Assistance of Kherson Regional Council, Male Department of Psychiatry #3, Female Department of Psychiatry #10,</name>
      <address>
        <city>Kherson</city>
        <zip>73488</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pavlo Palamarchuk, MD</last_name>
      <phone>+38504940457</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kyiv Clinical Hospital on Railway Station #1 of Healthcare Center branch of JSC &quot;Ukrainian Railway&quot;, Department of Psychoneurology</name>
      <address>
        <city>Kyiv</city>
        <zip>01030</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Military and Medical Clinical Center, The Main Military Clinical Hospital, Psychiatric Clinic with Wards for Narcological Patients</name>
      <address>
        <city>Kyiv</city>
        <zip>01133</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kyiv City Psychoneurological Hospital #2</name>
      <address>
        <city>Kyiv</city>
        <zip>02192</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladyslav Demchenko, MD</last_name>
      <phone>+38067 408 1203</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Territorial Medical Association Psychiatry in Kyiv, Center of Novel Methods of Treatment and Rehabilitation of Psychotic Conditions, Department #29 (male), Department #30 (female), Outpatient and Polyclinic Office at Department #30</name>
      <address>
        <city>Kyiv</city>
        <zip>04080</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuliya Blazhevych, MD</last_name>
      <phone>+380 50 384 70 48</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Institution of Kyiv Regional Council Regional Psychiatric and Narcological Medical Association, Male Department #10, Female Department #2</name>
      <address>
        <city>Kyiv</city>
        <zip>08631</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Communal Noncommercial Enterprise of Lviv Regional Council Lviv Regional clinical Psychiatric Hospital, Department #20</name>
      <address>
        <city>Lviv</city>
        <zip>79021</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kateryna Zakal</last_name>
      <phone>+380677672919</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communial Noncommercial Enterprise of Lviv Regional Council Lviv Regional Clinical Psychiatric Hospital, Department #25</name>
      <address>
        <city>Lviv</city>
        <zip>79021</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuriy Filts, MD</last_name>
      <phone>+380322954900</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>2-A Metalurgiv street</name>
      <address>
        <city>Nove</city>
        <zip>25491</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yevgen Denysov, MD</last_name>
      <phone>+38-050-564-10-35</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Non-commercial Enterprise Odesa Regional Medical Center of Mental Health of Odesa Regional Council, Department #6 (male), Department #12 (female)</name>
      <address>
        <city>Odesa</city>
        <zip>65006</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anatolii Voloshchuk</last_name>
      <phone>+380637356555</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Institution Odesa Regional Psychiatric Hospital #2, Department #14 (female), Department #16 (male)</name>
      <address>
        <city>Odesa</city>
        <zip>67513</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oleksandr Mykhaylyukovych, MD</last_name>
      <phone>+380677550464</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Institution O.I. Yushchenko Vinnytsia Regional Psychoneurological Hospital, Female Department #10, Male Department #7, Vinnytsia M.I.Pyrogov National Medical University, Chair of Psychiatry, Narcology and Psychotherapy with Postgraduate Education</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21005</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sofiia Rymsha, MD</last_name>
      <phone>+38 067-936-03-38</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Communal Institution O.I.Yushchenko Vinnytsia Regional Psychoneurological Hospital, Male Department #21, Female Department #15, M.I. Pyrogov Vinnytsia National Medical University, Chair of Psychiatry, Narcology and Psychotherapy with Postgraduate Educatio</name>
      <address>
        <city>Vinnytsia</city>
        <zip>21005</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Latvia</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 27, 2019</study_first_submitted>
  <study_first_submitted_qc>September 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>schizophrenia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>IPD for this study may be made available upon request via the Clinical Study Data Request site.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>IPD will be made available upon request within 12 months of posting the study results on ct.gov.</ipd_time_frame>
    <ipd_access_criteria>Access is provided after a research proposal is submitted and has received approval from the Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months but an extension can be granted, when justified, for up to another 12 months.</ipd_access_criteria>
    <ipd_url>http://clinicalstudydatarequest.com</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

